Manipulating IncRNAs to Disrupt Reconsolidation of Methamphetamine Associated Memories

操纵 IncRNA 破坏甲基苯丙胺相关记忆的重新巩固

基本信息

  • 批准号:
    9305902
  • 负责人:
  • 金额:
    $ 24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-07-01 至 2018-12-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Currently, clinicians can offer little hope to people addicted to psychostimulants, such as methamphetamine (METH). The memories associated with drug use and reward can bear a powerful motivational influence over behavior. Accordingly, the field is now working to develop strategies to manipulate the extinction and reconsolidation of cue-drug associations as novel treatment strategies to reduce their power to induce craving and relapse. Here we propose to study the contribution of a novel class of candidates, long- noncoding RNAs (lncRNAs), to METH-associated memory. An increasing number of functional studies indicate lncRNAs participate as regulators at almost every stage of gene expression, from epigenetic modifications in the nucleus to mRNA stability and translation in the cytoplasm. This regulatory potential, along with the abundance of lncRNAs, implies that lncRNAs may be part of a broad epigenetic network. Despite these functional insights, only a small number of lncRNAs have been studied in the nervous system and their contribution to substance use disorder (SUD) is unknown. Because of the transcriptional and translational roles lncRNAs, elucidating their function in regions of brain implicated in SUD will help identify novel therapeutic targets. The central hypothesis of this proposal, derived from our own preliminary studies, is that specific lncRNAs mediate reconsolidation of METH-associated memories. To test this hypothesis, we will employ animal models of drug seeking and relapse to identify and manipulate specific lncRNAs in vivo with the goal of preventing relapse by blocking reconsolidation.
项目摘要 目前,临床医生对精神兴奋剂成瘾的人几乎没有希望, 甲基苯丙胺(METH)。与药物使用和奖励相关的记忆可以承受强大的 动机对行为的影响。因此,该领域现在正在努力制定策略, 消除和重新巩固线索药物协会作为新的治疗策略,以减少他们的权力 来诱发渴望和复发在这里,我们建议研究一类新的候选人的贡献,长期- 非编码RNA(lncRNA),以甲基苯丙胺相关的记忆。越来越多的功能研究表明, lncRNA几乎在基因表达的每一个阶段都作为调节因子参与,从表观遗传修饰到基因表达。 细胞核对mRNA在细胞质中的稳定性和翻译的影响。这种监管潜力,沿着 lncRNA的丰度,意味着lncRNA可能是一个广泛的表观遗传网络的一部分。尽管有这些 由于功能上的见解,只有少量的lncRNA在神经系统中被研究, 对物质使用障碍(SUD)的贡献未知。由于转录和翻译的作用, lncRNA,阐明它们在涉及SUD的大脑区域的功能将有助于确定新的治疗方法, 目标的这一建议的中心假设来自我们自己的初步研究, lncRNA介导的METH相关记忆的再巩固。为了验证这一假设,我们将使用 药物寻找和复发的动物模型,以在体内鉴定和操纵特异性lncRNA, 通过阻断再巩固防止复发。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Courtney A Miller其他文献

Courtney A Miller的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Courtney A Miller', 18)}}的其他基金

Development of the AI-driven model for anti-SUD drug development based on neuronal plasticity
基于神经元可塑性的人工智能驱动抗SUD药物开发模型的开发
  • 批准号:
    10467528
  • 财政年份:
    2022
  • 资助金额:
    $ 24万
  • 项目类别:
Developing nonmuscle myosin II inhibitors for the treatment of glioblastoma
开发用于治疗胶质母细胞瘤的非肌肉肌球蛋白 II 抑制剂
  • 批准号:
    10557160
  • 财政年份:
    2021
  • 资助金额:
    $ 24万
  • 项目类别:
Developing nonmuscle myosin II inhibitors for the treatment of glioblastoma
开发用于治疗胶质母细胞瘤的非肌肉肌球蛋白 II 抑制剂
  • 批准号:
    10524193
  • 财政年份:
    2021
  • 资助金额:
    $ 24万
  • 项目类别:
Developing nonmuscle myosin II inhibitors for the treatment of glioblastoma
开发用于治疗胶质母细胞瘤的非肌肉肌球蛋白 II 抑制剂
  • 批准号:
    10595852
  • 财政年份:
    2021
  • 资助金额:
    $ 24万
  • 项目类别:
Impact of prenatal opioid exposure on long-range brain circuit connectivity and behavior
产前阿片类药物暴露对长程脑回路连接和行为的影响
  • 批准号:
    10163154
  • 财政年份:
    2020
  • 资助金额:
    $ 24万
  • 项目类别:
Impact of prenatal opioid exposure on long-range brain circuit connectivity and behavior
产前阿片类药物暴露对长程脑回路连接和行为的影响
  • 批准号:
    10060057
  • 财政年份:
    2020
  • 资助金额:
    $ 24万
  • 项目类别:
Myosin II regulation of actin dynamics and the selective vulnerability of methamphetamine- and opioid-associated memory
肌球蛋白 II 调节肌动蛋白动力学以及甲基苯丙胺和阿片类药物相关记忆的选择性脆弱性
  • 批准号:
    10533792
  • 财政年份:
    2019
  • 资助金额:
    $ 24万
  • 项目类别:
Myosin II regulation of actin dynamics and the selective vulnerability of methamphetamine- and opioid-associated memory
肌球蛋白 II 调节肌动蛋白动力学以及甲基苯丙胺和阿片类药物相关记忆的选择性脆弱性
  • 批准号:
    10596356
  • 财政年份:
    2019
  • 资助金额:
    $ 24万
  • 项目类别:
Myosin II regulation of actin dynamics and the selective vulnerability of methamphetamine- and opioid-associated memory
肌球蛋白 II 调节肌动蛋白动力学以及甲基苯丙胺和阿片类药物相关记忆的选择性脆弱性
  • 批准号:
    9916255
  • 财政年份:
    2019
  • 资助金额:
    $ 24万
  • 项目类别:
Integrated Platform for Discovery and Validation of Probes that Restore Protein Expression in Single-Gene Causes of Autism and Related Disorders
用于发现和验证可恢复自闭症及相关疾病单基因病因中蛋白质表达的探针的综合平台
  • 批准号:
    10153890
  • 财政年份:
    2017
  • 资助金额:
    $ 24万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 24万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 24万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了